Abstract:Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New drugs are required for ancillary support of existing malaria control efforts. Plasmodium falciparum requires host glucose for survival and proliferation. On this basis, P . falciparum hexose transporter 1 ( Pf HT1) protein involved in hexose permeation is considered a potential drug target. In this study, we tested the antimalarial activity of some compounds against Pf HT1 using computational techniques. We performed high throughput virtual screening of 21,352 small-molecule compounds against Pf HT1. The stability of the lead compound complexes was evaluated via molecular dynamics (MD) simulation for 100 nanoseconds. We also investigated the pharmacodynamic, pharmacokinetic and physiological characteristics of the compounds in accordance with Lipinksi rules for drug-likeness to bind and inhibit Pf HT1. Molecular docking and free binding energy analyses were carried out using Molecular Mechanics with Generalized Born and Surface Area (MMGBSA) solvation to determine the selectivity of the hit compounds for Pf HT1 over the human glucose transporter (hGLUT1) orthologue. Five important Pf HT1 inhibitors were identified: Hyperoside (CID5281643); avicularin (CID5490064); sylibin (CID5213); harpagoside (CID5481542) and quercetagetin (CID5281680). The compounds formed intermolecular interaction with the binding pocket of the Pf HT1 target via conserved amino acid residues (Val314, Gly183, Thr49, Asn52, Gly183, Ser315, Ser317, and Asn48). The MMGBSA analysis of the complexes yielded high free binding energies. Four (CID5281643, CID5490064, CID5213, and CID5481542) of the identified compounds were found to be stable within the Pf HT1 binding pocket throughout the 100 nanoseconds simulation run time. The four compounds demonstrated higher affinity for Pf HT1 than the human major glucose transporter (hGLUT1). This investigation demonstrates the inhibition potential of sylibin, hyperoside, harpagoside, and avicularin against Pf HT1 receptor. Robust preclinical investigations are required to validate the chemotherapeutic properties of the identified compounds.

The molecular basis for sugar import in malaria parasites

Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum

PfHT1 controls glucose uptake in malaria parasite: molecular dynamics study in plasma membrane like environment reveals ligand induced conformational changes trigger closed conformation and alters binding pocket geometry

Functional characterization of Plasmodium vivax hexose transporter 1

Basis of Glucose and Fructose Selectivity in Sugar Transport Proteins

Mechanistic Study of Human Glucose Transport Mediated by GLUT1

Biochemical characterization of a GDP-mannose transporter from Chaetomium thermophilum

Mechanism of Sugar Transport by A Phosphoenolpyruvate-Dependent Phosphotransferase

Structure and mechanism of a phosphotransferase system glucose transporter

Glucose-mediated expansion of a gut commensal bacterium promotes<i>Plasmodium</i>infection through alkalizing mosquito midgut

Structural and thermodynamic correlation illuminates the selective transport mechanism of disaccharide α‐glycosides through ABC transporter

Datamining and functional environmental genomics reassess the phylogenetics and functional diversity of fungal monosaccharide transporters

Glucose-mediated proliferation of a gut commensal bacterium promotes Plasmodium infection by increasing mosquito midgut pH

Glucose-mediated expansion of a gut commensal bacterium promotes Plasmodium infection through alkalizing mosquito midgut

Glucose Transporter GLUT1 Influences Plasmodium Berghei Infection in Anopheles Stephensi

Molecular Basis of Ligand Recognition and Transport by Glucose Transporters

Transmembrane IV of the high-affinity sodium-glucose cotransporter participates in sugar binding.

Functional Architecture of MFS D -Glucose Transporters

Protein:Protein interactions in the cytoplasmic membrane apparently influencing sugar transport and phosphorylation activities of the e. coli phosphotransferase system

Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.

Mobile barrier mechanisms for Na + -coupled symport in an MFS sugar transporter